Back to search
High-Risk Localized Prostate Cancer
Clinical trial pipeline · Data from ClinicalTrials.gov
See which High-Risk Localized Prostate Cancer trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which High-Risk Localized Prostate Cancer trials you may qualify forThis study aims to compare the novel single-port robotic partial prostatectomy to High-intensity focused ultrasound (HIFU) in patients with low to intermediate…
To learn about the safety and effects of a drug called REGN5678 when it is given to patients with high-risk prostate cancer.
This pilot clinical trial studies how well magnetic resonance spectroscopic imaging (MRSI) with hyperpolarized carbon 13 (13C) pyruvate alone or in combination…
The purpose of the study is to demonstrate superiority of Saruparib (AZD5305) relative to placebo added to a standard radiation therapy (RT) + androgen deprivat…
The Sonablate HIFU device was approved by the U.S.FDA for prostate tissue ablation in October, 2015. The purpose of this observational research study is to inve…
The purpose of this study is to see whether combining 2141-V11 with various standard treatments is an effective treatment approach for prostate cancer. 2141-V11…
The purpose of this study is to determine if apalutamide plus gonadotropin releasing hormone (GnRH) agonist in participants with high-risk, localized or locally…
The purpose of this study is to determine if treatment with apalutamide plus androgen deprivation therapy (ADT) before and after radical prostatectomy (RP) with…